Romano Brothers AND Company decreased its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 41.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 37,807 shares of the real estate investment trust's stock after selling 27,247 shares during the period. Romano Brothers AND Company's holdings in Healthpeak Properties were worth $766,000 as of its most recent filing with the SEC.
Several other large investors have also modified their holdings of DOC. State Street Corp acquired a new stake in Healthpeak Properties during the third quarter valued at approximately $1,093,576,000. Geode Capital Management LLC acquired a new position in Healthpeak Properties during the 3rd quarter valued at approximately $403,898,000. Charles Schwab Investment Management Inc. bought a new position in shares of Healthpeak Properties during the third quarter worth about $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Healthpeak Properties in the 3rd quarter worth about $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. bought a new position in Healthpeak Properties in the 3rd quarter worth approximately $102,615,000. Institutional investors own 93.57% of the company's stock.
Healthpeak Properties Trading Up 0.5 %
NYSE DOC traded up $0.10 during trading on Friday, reaching $20.80. 3,246,701 shares of the stock traded hands, compared to its average volume of 3,712,150. The stock's 50-day moving average price is $20.90 and its 200 day moving average price is $21.52. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93. The firm has a market cap of $14.55 billion, a price-to-earnings ratio of 44.26, a price-to-earnings-growth ratio of 2.12 and a beta of 1.14. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by ($0.32). The firm had revenue of $700.40 million during the quarter, compared to analyst estimates of $682.51 million. Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. Healthpeak Properties's quarterly revenue was up 25.9% on a year-over-year basis. During the same period last year, the firm earned $0.45 EPS. Analysts predict that Healthpeak Properties, Inc. will post 1.81 EPS for the current year.
Healthpeak Properties Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were issued a $0.30 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $1.20 annualized dividend and a dividend yield of 5.77%. Healthpeak Properties's dividend payout ratio (DPR) is currently 255.32%.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on DOC shares. Wells Fargo & Company lowered their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Tuesday, December 10th. Mizuho decreased their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a report on Thursday, December 5th. Royal Bank of Canada upped their price target on Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a research report on Monday, November 4th. Morgan Stanley upgraded shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price for the company in a research report on Wednesday. Finally, Robert W. Baird lifted their price target on Healthpeak Properties from $24.00 to $25.00 and gave the company an "outperform" rating in a report on Wednesday, October 30th. One analyst has rated the stock with a sell rating, three have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Healthpeak Properties has an average rating of "Moderate Buy" and a consensus price target of $24.15.
Get Our Latest Stock Report on Healthpeak Properties
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
